Issue 13 September/October 2011
Quantum
This approach uses light as a sensory input because light is a medium which can be adapted for diagnostic and therapeutic effect. Every protein is visually active—it absorbs and emits light according to the rate at which the protein is expressed from DNA and the rate that it reacts with its reactive substrate. In effect, by selecting the colour defi ciency, we can characterise the nature and extent of each emergent pathology, and by providing a uniquely designed colour supplement we can treat the condition, as explained further below. There are many precedents for this. For example, the company BioAstral is developing a modifi ed astronomical detector that instead of pointing at the stars is detecting the light emitted from blood samples. And, although fl ashing lights can cause photosensitivity in people with migraines and epilepsy, it can also be used as a therapy, and in fact has been approved as such to treat migraine, dyslexia, and (in the US) a range of other conditions. Another therapy, called Virtual Scanning, is based upon the link between brain data processing and organ function and sensory input, such as by light/colour.
The Virtual Scanner is a colour cognition assessment and treatment system, using precise light frequencies in the visible light spectrum, that is based upon the mathematical model developed by Dr I.G. Grakov that I mentioned above and his research into how organs respond to coloured- light stimulation. Using a computer, a client takes a colour “test” that takes about ten to fi fteen minutes. The computer returns results that show an assessment of where the client may be making persistent, systematic errors in “colour cognition.” On the basis of that test of errors in colour cognition, results are returned about the state of the health and function of thirty organs.
Research has shown that particular types of organ pathologies infl uence how the brain processes colour as a sensory input. The principle applies in reverse, as the Virtual Scanner uses colours that are correlated to the organ that has the pathology and delivers those precise frequencies in the delta band of EEG. In effect, the system uses the “virtual” reality of the way the brain
www.quantumhealthmagazine.com
processes colour information to both scan the client to detect problems and then to affect the “real” organ in the treatment phase. The process is one of feedback among colour cognition, organ function, and the brain’s sensory data processing mechanisms. While this approach has been well-studied, and verifi ed in Russia, it is only now making inroads in other countries, especially in the United Kingdom.
Conclusion
It is increasingly clear that there are principles about physiology that orthodox biomedicine has yet to understand, let alone embrace. Most of the orthodox biomedical techniques are based upon identifying and treating the symptoms of disease. By contrast, CAM techniques adopt an understanding of the mechanisms that the body naturally employs to regulate its function and that, in the case of stress and disease, becomes disturbed. CAM techniques are based upon a viable scientifi c principle, but we have to ask to what extent they can be adapted with therapeutic effect. As we see in the case of acupuncture and nutrition, the medical profession will slowly accept innovative approaches if they are accompanied by a body of evidence.
Many medical conditions have complex multi-systemic or multi-genetic origins. As a consequence, they are poorly defi ned. The failure to consider the multi-systemic nature of the body’s function is a particular failing of the genetic paradigm. The understanding of the roles played by light and colour may have signifi cant benefi t for both the diagnosis and treatment of disease. Such techniques might even present the way to better medical diagnoses, better methods of preventing and/or treating disease, and a better understanding of the limitations of orthodox biomedicine.
Graham Ewing is Chief Executive Offi cer and Director of Montague Healthcare, in Nottingham, England. He is devoted to the commercialisation of Virtual Scanning. You can contact him at
graham.ewing@montague-diagnostics.co.uk or
graham.ewing@montaguehealthcare.co.uk.
HEALTH
Quantum Health 37
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48